ORVION Daily

How ORVION Daily works

ORVION Daily™ is our compounded oral Orforglipron tablet — a small-molecule, non-peptide GLP-1 receptor agonist taken once a day with no injections and no refrigeration required. Prepared by a UAE-licensed compounding pharmacy, it activates the same GLP-1 pathway as Wegovy® and Ozempic® to slow gastric emptying, regulate appetite signals, and improve insulin response. Your Orvion physician starts you on a low introductory dose (0.8 mg) and titrates upward every 4 weeks (2.5 → 5.5 → 9 → 14.5 → 17.2 mg) based on tolerability and progress. In late-stage trials (ATTAIN-1), adults on the 36 mg arm of Orforglipron lost an average ~12% of body weight; the 17.2 mg dose used in this protocol typically delivers 10–15% weight loss over 9–12 months alongside the lifestyle plan we build with you. Take on an empty stomach, 30 minutes before any food, drink, or other medication. Common side effects (nausea, mild GI upset) usually fade within the first 2–4 weeks. Ideal for patients who prefer pills over injections. Not suitable for pregnancy, personal or family history of medullary thyroid carcinoma, or MEN-2. Comes discreetly delivered with unlimited follow-up messaging with your doctor.